Follow
Ravi Amaravadi
Ravi Amaravadi
Verified email at uphs.upenn.edu
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13351*2021
Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib
JA Sosman, KB Kim, L Schuchter, R Gonzalez, AC Pavlick, JS Weber, ...
New England Journal of Medicine 366 (8), 707-714, 2012
25522012
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
C Twyman-Saint Victor, AJ Rech, A Maity, R Rengan, KE Pauken, ...
Nature 520 (7547), 373-377, 2015
22882015
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ...
Nature 545 (7652), 60-65, 2017
14622017
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
RK Amaravadi, D Yu, JJ Lum, T Bui, MA Christophorou, GI Evan, ...
The Journal of clinical investigation 117 (2), 326-336, 2007
14062007
Autophagy in malignant transformation and cancer progression
L Galluzzi, F Pietrocola, JM Bravo‐San Pedro, RK Amaravadi, ...
The EMBO journal 34 (7), 856-880, 2015
12332015
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
M Buzzai, RG Jones, RK Amaravadi, JJ Lum, RJ DeBerardinis, F Zhao, ...
Cancer research 67 (14), 6745-6752, 2007
11152007
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
O Khan, JR Giles, S McDonald, S Manne, SF Ngiow, KP Patel, MT Werner, ...
Nature 571 (7764), 211-218, 2019
10812019
Principles and current strategies for targeting autophagy for cancer treatment
RK Amaravadi, J Lippincott-Schwartz, XM Yin, WA Weiss, N Takebe, ...
Clinical cancer research 17 (4), 654-666, 2011
10112011
Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade
JL Benci, B Xu, Y Qiu, TJ Wu, H Dada, C Twyman-Saint Victor, L Cucolo, ...
Cell 167 (6), 1540-1554. e12, 2016
10092016
Recent insights into the function of autophagy in cancer
R Amaravadi, AC Kimmelman, E White
Genes & development 30 (17), 1913-1930, 2016
7612016
Autophagy in major human diseases
DJ Klionsky, G Petroni, RK Amaravadi, EH Baehrecke, A Ballabio, P Boya, ...
The EMBO journal 40 (19), e108863, 2021
7142021
Targeting autophagy in cancer: recent advances and future directions
RK Amaravadi, AC Kimmelman, J Debnath
Cancer discovery 9 (9), 1167-1181, 2019
6562019
Targeting autophagy in cancer
AV Onorati, M Dyczynski, R Ojha, RK Amaravadi
Cancer 124 (16), 3307-3318, 2018
6112018
The roles of therapy-induced autophagy and necrosis in cancer treatment
RK Amaravadi, CB Thompson
Clinical cancer research 13 (24), 7271-7279, 2007
6072007
Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms
JC Beltra, S Manne, MS Abdel-Hakeem, M Kurachi, JR Giles, Z Chen, ...
Immunity 52 (5), 825-841. e8, 2020
5542020
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ...
Nature medicine 25 (3), 454-461, 2019
5422019
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
MR Rosenfeld, X Ye, JG Supko, S Desideri, SA Grossman, S Brem, ...
Autophagy 10 (8), 1359-1368, 2014
5122014
Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma
PA Ascierto, D Minor, A Ribas, C Lebbe, A O’Hagan, N Arya, M Guckert, ...
J Clin Oncol 31 (26), 3205-3211, 2013
5022013
The survival kinases Akt and Pim as potential pharmacological targets
R Amaravadi, CB Thompson
The Journal of clinical investigation 115 (10), 2618-2624, 2005
4972005
The system can't perform the operation now. Try again later.
Articles 1–20